Dr. Michael G. Bodnar, MD

Dr. Bodnar practices at Conejo Dermatology in Thousand Oaks, California.

Dr. Bodnar's NPI, 1740296698, was assigned on July 31, 2006. Dr. Bodnar graduated from Loyola University Chicago Stritch School of Medicine in 1994. Dr. Bodnar holds California license A00064258.

Dr. Bodnar's primary practice is Conejo Dermatology, at 55 Rolling Oaks Dr, Ste 200, Thousand Oaks, CA 91361. The practice phone is (805) 497-7529.

Dr. Bodnar's primary practice is Conejo Dermatology in Thousand Oaks, California. The medical group on file is West Dermatology. Dmand AI also links Dr. Bodnar to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bodnar practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Bodnar's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bodnar is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Bodnar's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Bodnar treats.

CMS data shows 35,516 Medicare services from Dr. Bodnar across 26 procedure codes in 2024, for 1,685 Medicare patients. Medicare paid $1,121,651 for them. Every service was in an office.

CMS counts 1,685 Medicare patients who saw Dr. Bodnar in 2024. The largest group is 65 to 74, with 736 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bodnar's median patient age at 68, with 46% women.

In 2024, Dr. Bodnar wrote 1,423 Medicare Part D claims for 631 patients. 97% of them were for generic drugs. CMS names the drug for 1,325 of them, across 19 drugs with 11 or more claims each, at $34,552 in total drug cost. In 2023, CMS named 1,090 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Bodnar for performance year 2024, reported as part of a group. Dr. Bodnar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 9,649 procedures of removal of skin lesions by Dr. Bodnar, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Bodnar in 2024. Dr. Bodnar's most frequent co-author is Matthew J. Mifsud, MD.

CMS Open Payments shows 212 general payments to Dr. Bodnar from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Sanofi and Genzyme US Companies paid the most, $999.

Dr. Bodnar graduated from Loyola University Chicago Stritch School of Medicine in 1994.

Dr. Bodnar is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.